Senseonics Holdings Inc (AMEX:SENS)
$ 0.3114 0.0034 (1.1%) Market Cap: 184.54 Mil Enterprise Value: 168.18 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Senseonics Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 11:20AM GMT
Release Date Price: $1.53 (-6.71%)
Neha Begwani

Thank you, everybody, for joining us for the second day of the Morgan Stanley Healthcare Conference. My name is Neha Begwani and I'm part of the Morgan Stanley Investment Banking team. I'm pleased to be joined by the Senseonics Group here. We have Tim Goodnow, CEO; and Rick Sullivan, CFO. Before we jump into today's discussion, I want to do the quick disclosure. So please see Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to Morgan Stanley sales representatives.

And with that, maybe to kick us off, if you can give us a brief overview of the company, the Eversense technology. It's a very exciting, important platform So Just to kind of level set today's discussion.

Timothy T. Goodnow
Senseonics Holdings, Inc. - President, CEO & Director

Sure. Well, we appreciate the opportunity to speak today and thank to folks at Morgan Stanley for having us. So Senseonics is a medical technology company, obviously, in the continuous glucose monitoring space. We've been at this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot